Oestrogen receptor polymorphisms are an associated risk factor for mild cognitive impairment and Alzheimer disease in women APOE ɛ4 carriers: a case

Oestrogen receptor polymorphisms are an associated risk factor for mild cognitive impairment and Alzheimer disease in women APOE ɛ4 carriers: a case–control study

Published:2013-09 Issue:9 Volume:3 Page:e003200
ISSN:2044-6055
Container-title:BMJ Open
language:en
Short-container-title:BMJ Open

Author:

Fernández-Martínez Manuel,Elcoroaristizabal Martín Xabier,Blanco Martín Elisa,Galdos Alcelay Luis,Ugarriza Serrano Iratxe,Gómez Busto Fernando,Álvarez-Álvarez Maite,Molano Salazar Ana,Bereincua Gandarias Rocio,Inglés Borda Sandra,Uterga Valiente Juan María,Indakoetxea Juanbeltz Begoña,Gómez Beldarraín María Ángeles,Moraza López Josefa,Barandiarán Amillano Myriam,M de Pancorbo Marian

Publisher

BMJ

Subject

General Medicine

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Estrogen Receptor 1 PvuII and XbaI Polymorphisms and Peripheral Estrogen Receptor 1 mRNA Levels with Alzheimer’s Disease in Turkish Patients;Turkish Journal Of Neurology;2023-10-02

2. Association of Estrogen Receptor 1 (ESR1) PvuII and XbaI polymorphisms and peripheral ESR1 mRNA levels with Alzheimer's disease;2023-03-13

3. Role of estrogen in women's Alzheimer's disease risk as modified by APOE ;Journal of Neuroendocrinology;2022-11-24

4. Genomics as a Clinical Decision Support Tool for Identifying and Addressing Modifiable Causes of Cognitive Decline and Improving Outcomes: Proof of Concept Support for This Personalized Medicine Strategy;Frontiers in Aging Neuroscience;2022-04-18

5. Neurobiological Highlights of Cognitive Impairment in Psychiatric Disorders;International Journal of Molecular Sciences;2022-01-22